A Critical Analysis and Discussion of the Appropriateness of the Schizophrenia Consensus Remission Criteria in Clinical Pharmaceutical Trials
- 6 October 2010
- journal article
- research article
- Published by Georg Thieme Verlag KG in Pharmacopsychiatry
- Vol. 43 (07) , 245-251
Abstract
Background: The aim of this paper is to apply the proposed consensus remission criteria to an acutely ill inpatient sample at admission and evaluate their adaptability in this patient population and pharmaceutical trials. Methods: The Remission in Schizophrenia Working Group's consensus criteria were applied to 272 acutely ill schizophrenia patients. Patients were examined using the PANSS, HAMD, UKU and SWN-K total scales at admission as well as the GAF, SOFAS and the Strauss-Carpenter Prognostic Scale. Sociodemographic and clinical baseline variables were assessed using a standardized documentation system. Results: 33 patients (12%) fulfilled the symptom severity component of the proposed remission criteria already at baseline. Almost no significant differences were found when comparing patients with achieved and failed symptom severity component that would explain the hospitalization of the patients with achieved criteria despite their apparently mild psychopathological symptoms. The only explainable difference was that patients with an achieved symptom severity component had received significantly more antipsychotics and had suffered from significantly more life events before admission. Conclusion: The present results raise the question whether the symptom severity threshold is adequate to identify patients in remission when applied in clinical trials.Keywords
This publication has 11 references indexed in Scilit:
- Standardised rating scales in Psychiatry: Methodological basis, their possibilities and limitations and descriptions of important rating scalesThe World Journal of Biological Psychiatry, 2009
- Definitions of response and remission in schizophrenia: recommendations for their use and their presentationActa Psychiatrica Scandinavica, 2008
- The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric traditionEuropean Archives of Psychiatry and Clinical Neuroscience, 2008
- Outcomes in major depressive disorder: The evolving concept of remission and its implications for treatmentThe World Journal of Biological Psychiatry, 2008
- The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidoneSchizophrenia Research, 2007
- On the concept of remission in schizophreniaPsychopharmacology, 2007
- Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disordersEuropean Archives of Psychiatry and Clinical Neuroscience, 2006
- Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injectionSchizophrenia Research, 2005
- Direct transition to long-acting risperidone - analysis of long-term efficacyJournal of Psychopharmacology, 2005
- German research network on schizophreniaEuropean Archives of Psychiatry and Clinical Neuroscience, 2003